Alisol B
CAS No. 18649-93-9
Alisol B( —— )
Catalog No. M20406 CAS No. 18649-93-9
Alisol B may be a potential novel therapeutic molecule for bone disorders through targeting the differentiation of osteoclasts as well as their functions.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 188 | In Stock |
|
| 5MG | 187 | In Stock |
|
| 10MG | 278 | In Stock |
|
| 25MG | 472 | In Stock |
|
| 50MG | 644 | In Stock |
|
| 100MG | 913 | In Stock |
|
| 200MG | 1228 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAlisol B
-
NoteResearch use only, not for human use.
-
Brief DescriptionAlisol B may be a potential novel therapeutic molecule for bone disorders through targeting the differentiation of osteoclasts as well as their functions.
-
DescriptionAlisol B may be a potential novel therapeutic molecule for bone disorders through targeting the differentiation of osteoclasts as well as their functions. Alisol B also inhibited RANKL-induced expression of NFATc1 and c-Fos which are key transcription factors for osteoclastogenesis.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorRANKL
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number18649-93-9
-
Formula Weight472.7
-
Molecular FormulaC30H48O4
-
Purity>98% (HPLC)
-
SolubilityDMSO:95 mg/mL (200.97 mM)
-
SMILES[H][C@@]1(OC1(C)C)[C@@H](O)C[C@@H](C)C1=C2C[C@H](O)[C@@]3([H])[C@@]4(C)CCC(=O)C(C)(C)[C@]4([H])CC[C@]3(C)[C@@]2(C)CC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Lee J W Kobayashi Y Nakamichi Y et al. Alisol-B a novel phyto-steroid suppresses the RANKL-induced osteoclast formation and prevents bone loss in mice[J]. Biochemical Pharmacology 2010 80(3):352-361.
molnova catalog
related products
-
Mukanadin C
Mukanadin C is a marine derived natural products found in Stylissa carteri.
-
Bexmarilimab
Bexmarilimab (FP-1305) is a highly potent, humanized anti-CLEVER-1 IgG4 antibody with an IC50 value of 4.51 nM, promoting immune conversion of tumor-associated macrophage phenotype M2 to M1, and can be used to study cancer.
-
EC23
EC23 is a stable synthetic retinoid analogue. It is also induces neuronal differentiation.
Cart
sales@molnova.com